111 related articles for article (PubMed ID: 18538948)
21. Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice.
Persigehl T; Bieker R; Matuszewski L; Wall A; Kessler T; Kooijman H; Meier N; Ebert W; Berdel WE; Heindel W; Mesters RM; Bremer C
Radiology; 2007 Aug; 244(2):449-56. PubMed ID: 17562810
[TBL] [Abstract][Full Text] [Related]
22. Patupilone induced vascular disruption in orthotopic rodent tumor models detected by magnetic resonance imaging and interstitial fluid pressure.
Ferretti S; Allegrini PR; O'Reilly T; Schnell C; Stumm M; Wartmann M; Wood J; McSheehy PM
Clin Cancer Res; 2005 Nov; 11(21):7773-84. PubMed ID: 16278399
[TBL] [Abstract][Full Text] [Related]
23. Effects of 5,6-dimethylxanthenone-4-acetic acid on human tumor microcirculation assessed by dynamic contrast-enhanced magnetic resonance imaging.
Galbraith SM; Rustin GJ; Lodge MA; Taylor NJ; Stirling JJ; Jameson M; Thompson P; Hough D; Gumbrell L; Padhani AR
J Clin Oncol; 2002 Sep; 20(18):3826-40. PubMed ID: 12228202
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of magnetic resonance vessel size imaging by two-photon laser scanning microscopy.
Douma K; Oostendorp M; Slaaf DW; Post MJ; Backes WH; van Zandvoort MA
Magn Reson Med; 2010 Apr; 63(4):930-9. PubMed ID: 20373394
[TBL] [Abstract][Full Text] [Related]
25. Use of photoacoustic imaging for monitoring vascular disrupting cancer treatments.
Fadhel MN; Appak Baskoy S; Wang Y; Hysi E; Kolios MC
J Biophotonics; 2023 Apr; 16(4):e202000209. PubMed ID: 32888381
[TBL] [Abstract][Full Text] [Related]
26. Assessment of absolute blood volume in carcinoma by USPIO contrast-enhanced MRI.
Gambarota G; van Laarhoven HW; Philippens M; Lok J; van der Kogel A; Punt CJ; Heerschap A
Magn Reson Imaging; 2006 Apr; 24(3):279-86. PubMed ID: 16563957
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic modeling of phagocytic activity of the liver using superparamagnetic iron oxide nanoparticles in dynamic MR imaging.
Na JB; Suh JS; Huh YM; Kim SJ; Kim SH; Cha SH; Lee SH
Yonsei Med J; 2003 Jun; 44(3):429-37. PubMed ID: 12833580
[TBL] [Abstract][Full Text] [Related]
28. Detecting vascular-targeting effects of the hypoxic cytotoxin tirapazamine in tumor xenografts using magnetic resonance imaging.
Bains LJ; Baker JH; Kyle AH; Minchinton AI; Reinsberg SA
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):957-65. PubMed ID: 19480975
[TBL] [Abstract][Full Text] [Related]
29. Characterizing blood volume fraction (BVF) in a VX2 tumor.
Qi XL; Burns P; Hong J; Stainsby J; Wright G
Magn Reson Imaging; 2008 Feb; 26(2):206-14. PubMed ID: 17683893
[TBL] [Abstract][Full Text] [Related]
30. MR contrast due to intravascular magnetic susceptibility perturbations.
Boxerman JL; Hamberg LM; Rosen BR; Weisskoff RM
Magn Reson Med; 1995 Oct; 34(4):555-66. PubMed ID: 8524024
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous assessment of vessel size index, relative blood volume, and vessel permeability in a mouse brain tumor model using a combined spin echo gradient echo echo-planar imaging sequence and viable tumor analysis.
Kording F; Weidensteiner C; Zwick S; Osterberg N; Weyerbrock A; Staszewski O; von Elverfeldt D; Reichardt W
J Magn Reson Imaging; 2014 Dec; 40(6):1310-8. PubMed ID: 24390982
[TBL] [Abstract][Full Text] [Related]
32. Predictability of FTY720 efficacy in experimental autoimmune encephalomyelitis by in vivo macrophage tracking: clinical implications for ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Rausch M; Hiestand P; Foster CA; Baumann DR; Cannet C; Rudin M
J Magn Reson Imaging; 2004 Jul; 20(1):16-24. PubMed ID: 15221804
[TBL] [Abstract][Full Text] [Related]
33. Vessel size index measurements in a rat model of glioma: comparison of the dynamic (Gd) and steady-state (iron-oxide) susceptibility contrast MRI approaches.
Pannetier N; Lemasson B; Christen T; Tachrount M; Troprès I; Farion R; Segebarth C; Rémy C; Barbier EL
NMR Biomed; 2012 Feb; 25(2):218-26. PubMed ID: 21751270
[TBL] [Abstract][Full Text] [Related]
34. Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma.
Jassar AS; Suzuki E; Kapoor V; Sun J; Silverberg MB; Cheung L; Burdick MD; Strieter RM; Ching LM; Kaiser LR; Albelda SM
Cancer Res; 2005 Dec; 65(24):11752-61. PubMed ID: 16357188
[TBL] [Abstract][Full Text] [Related]
35. Definition of liver tumors in the presence of diffuse liver disease: comparison of findings at MR imaging with positive and negative contrast agents.
Kuwatsuru R; Brasch RC; Mühler A; Mathur A; Vexler VS; Rosenau W; Mintorovitch J; Berthezene Y; Cohen F; Shames DM
Radiology; 1997 Jan; 202(1):131-8. PubMed ID: 8988202
[TBL] [Abstract][Full Text] [Related]
36. Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling.
Yancy AD; Olzinski AR; Hu TC; Lenhard SC; Aravindhan K; Gruver SM; Jacobs PM; Willette RN; Jucker BM
J Magn Reson Imaging; 2005 Apr; 21(4):432-42. PubMed ID: 15779033
[TBL] [Abstract][Full Text] [Related]
37. Cerebral blood volume estimation by ferumoxytol-enhanced steady-state MRI at 9.4 T reveals microvascular impact of α1 -adrenergic receptor antibodies.
Pohlmann A; Karczewski P; Ku MC; Dieringer B; Waiczies H; Wisbrun N; Kox S; Palatnik I; Reimann HM; Eichhorn C; Waiczies S; Hempel P; Lemke B; Niendorf T; Bimmler M
NMR Biomed; 2014 Sep; 27(9):1085-93. PubMed ID: 25060359
[TBL] [Abstract][Full Text] [Related]
38. Vessel size imaging.
Troprès I; Grimault S; Vaeth A; Grillon E; Julien C; Payen JF; Lamalle L; Décorps M
Magn Reson Med; 2001 Mar; 45(3):397-408. PubMed ID: 11241696
[TBL] [Abstract][Full Text] [Related]
39. Antitumour action of 5,6-dimethylxanthenone-4-acetic acid in rats bearing chemically induced primary mammary tumours.
Liu JJ; Ching LM; Goldthorpe M; Sutherland R; Baguley BC; Kirker JA; McKeage MJ
Cancer Chemother Pharmacol; 2007 Apr; 59(5):661-9. PubMed ID: 16944150
[TBL] [Abstract][Full Text] [Related]
40. Quantitative assessment of uptake and distribution of iron oxide particles (NC100150) in human melanoma xenografts by contrast-enhanced MRI.
Graff BA; Vangberg L; Rofstad EK
Magn Reson Med; 2004 Apr; 51(4):727-35. PubMed ID: 15065245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
